Estratto
Il dolore nei pazienti con cancro è un sintomo che richiede una attenta valutazione ed un trattamento adeguato. L’importanza del problema risulta evidente sia dalle stime di prevalenza dell’ Organizzazione Mondiale della Sanità (OMS), in cui risulta che il 30% dei pazienti sottoposti ad un trattamento attivo ed il 70% dei pazienti con tumore in fase avanzata presentano dolore dovuto alla progressione di malattia, sia dal grave impatto sulla qualità di vita legato all’intensità e alla persistenza del sintomo. La presenza cronica di dolore infatti interferisce con le attività quotidiane, le relazioni sociali, l’autonomia e con l’equilibrio psicologico del paziente.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Caraceni A, Portenoy RK (1999) a working group of the IASP task force on cancer pain. An international survey of cancer pain characteristics and syndromes. Pain 82:263–274
Front D, Schneck S, Frankel A, Robinson E (1974) Bone metastases and bone pain in breast cancer. Are they closely associated. JAMA 242:1747–1748
Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69:1–8
Hanks G, De Conno F, Cherny N et al (2001) Morphine and alternative opioids in cancer pain the EAPC recommendations. Br J Cancer 84:587–593
Ventafridda V, Tamburini M, Caraceni A et al (1987) A validation study of the WHO method for cancer pain relief. Cancer 59:851–856
De Conno F, Caraceni A (1996) Manual of cancer pain. Kluwer Academic Publishers, Dordrecht
Expert Working Group of the European Association for Palliative Care (1996) Morphine in cancer pain: modes of administration. BMJ 312:823–826
Klepstad P, Kaasa S, Jystad A et al (2003) Immediate-or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain 101:193–198
De Conno F, Groff L, Brunelli C et al (1996) Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol 14:2836–2842
Cherny NJ, Chang V, Frager G et al (1995) Opioid pharmacotherapy in the management of cancer pain. A survey of strategies used by pain physisicians for the selection of analgesic drugs and routes of administration. Cancer 76:1288–1293
Coyle N, Adelhardt J, Foley KM, Portenoy RK (1990) Character of terminal illness in the advanced cancer patient: pain and other symptoms during last four weeks of life. J Pain Symptom Manage 5:83–89
Bruera E, Pereira J, Watanabe S et al (1996) Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 78:852–857
Derby S, Chin JL, Portenoy R (1998) Systemic opioid therapy for chronic cancer pain: practical guidelines for converting drugs and routes of administration. CNS Drugs 9:99–109
Ripamonti C, Groff L, Brunelli C et al (1998) Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 16:3216–3221
Mercadante S, Casuccio A, Calderone L (1999) Rapid switching from morphine to methadone in cancer patients with poor response to morphine. J Clin Oncol 17:3307–3312
Mercadante S, Casuccio A, Fulfaro F et al (2001) Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 19:2898–2904
McNicol E, Strassels S, Goudas L et al (2004) Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review. J Clin Oncol 22:1975–1992
McQuay H, Carroll D, Jadad AR et al (1995) Anticonvulsants drugs for management of pain: a systematic review. BMJ 311:1047–1052
Sindrup SH, Jensen TS (1999) Efficacy of pharmacologial treatments of neuropathic pain: an update and effect related to mechanism of drug actin. Pain 83:389–400
Watanabe S, Bruera E (1994) Corticosteroids as adjuvant analgesics. J Pain Symptom Manage 9:442–445
Vecht CJ, Haaxma-Reiche H, van Putten WLJ et al (1989) Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 39:1255–1257
De Conno F, Caraceni A, Aldrighetti L et al (1993) Paraplegia following coeliac plexus block. Pain 55:383–385
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia, Milano
About this chapter
Cite this chapter
Martini, C., Zecca, E. (2006). Il dolore in oncologia. In: Le complicazioni neurologiche in oncologia. Springer, Milano. https://doi.org/10.1007/978-88-470-0440-5_18
Download citation
DOI: https://doi.org/10.1007/978-88-470-0440-5_18
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0439-9
Online ISBN: 978-88-470-0440-5
eBook Packages: MedicineMedicine (R0)